Filter
5520
Filtered Results: 5520
Text search:
drug
development
Featured
Recommendations
475
New Publications
1473
Language
Document type
No document type
3359
Studies & Reports
868
Guidelines
665
Manuals
238
Strategic & Response Plan
170
Fact sheets
79
Training Material
78
Situation Updates
20
Infographics
14
Resource Platforms
11
Brochures
8
Online Courses
7
Dashboards/Maps
1
App
1
Videos
1
Countries / Regions
India
314
Global
198
Kenya
175
South Africa
133
Ethiopia
130
Uganda
127
Nigeria
117
Western and Central Europe
110
Tanzania
103
Nepal
101
Sierra Leone
92
Liberia
89
Zambia
88
Malawi
85
Myanmar / Burma
80
Latin America and the Carribbean
74
Ghana
73
Africa
72
Bangladesh
72
Rwanda
65
Ukraine
57
Eastern Europe
57
Philippines
52
Namibia
52
Zimbabwe
44
Asia
43
South–East Asia Region
40
Cambodia
39
Russia
38
Lesotho
37
Indonesia
32
Botswana
29
Congo, Democratic Republic of
28
Mozambique
27
Syria
23
Eswatini/ Swaziland
23
Senegal
21
Burkina Faso
20
Colombia
19
Germany
19
Brazil
17
South Sudan
17
Cameroon
16
East and Southern Africa
16
USA
15
West and Central Africa
15
Haiti
14
Middle East and North Africa
14
Tajikistan
13
Albania
12
Venezuela
12
Pakistan
11
Thailand
10
China
10
Guinea
10
Afghanistan
9
Eastern Europe and Central Asia
9
Vietnam
9
Georgia
9
Argentina
8
Sudan
8
Armenia
7
Paraguay
7
Moldova
7
Mexico
6
Laos
6
Western Pacific Region
6
North America
6
Sri Lanka
6
Yemen
6
North Macedonia
5
Benin
5
Peru
5
Lebanon
5
Central African Republic
5
Iraq
5
El Salvador
4
Iran
4
Jordan
4
Jamaica
4
United Kingdom
4
Bhutan
4
Somalia
4
Madagascar
4
Timor Leste/ East Timor
3
Turkey
3
Fiji
3
Kyrgyzstan
3
Côte d’Ivoire / Ivory Coast
3
Bolivia
3
Papua New Guinea
3
Palestine
3
Mali
3
Angola
3
Libya
3
Serbia
2
Kazakhstan
2
Chile
2
Canada
2
Estonia
2
Uzbekistan
2
Morocco
2
Guinea-Bissau
2
Hungary
2
Saudi Arabia
2
France
2
Portugal
2
Spain
2
Belarus
2
Southern Africa
2
Poland
2
Honduras
2
Ecuador
2
North Korea
1
Switzerland
1
Australia
1
Gambia
1
Singapore
1
Congo-Brazzaville
1
Niger
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Ireland
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Nicaragua
1
Egypt
1
Romania
1
Greece
1
Chad
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
2147
Clinical Guidelines
472
Public Health
266
Women & Child Health
214
Key Resources
155
Capacity Building
76
Pharmacy & Technologies
63
Annual Report MEDBOX
1
Toolboxes
HIV
621
Mental Health
549
TB
526
AMR
287
NTDs
240
COVID-19
207
Pharmacy
161
NCDs
117
Caregiver
108
Rapid Response
92
Ebola & Marburg
81
Planetary Health
78
Refugee
70
Malaria
66
Disability
65
Global Health Education
61
Conflict
58
Health Financing Toolbox
53
Polio
22
Natural Hazards
21
Specific Hazards
16
Cholera
16
Zika
16
Social Ethics
14
: interim guidance, 17 February 2021
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding quickly and outlines key actions and measures that...
There is a broad consensus nowadays that the Earth is warming up as a result of greenhouse gas emissions caused by anthropogenic activities. It is also clear that current trends in the fields of energy, development and population growth will lead to continuous and ever more dramatic climate change. ...
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o...
Antimicrobial resistance (AMR) is a complex issue of global concern. AMR is not simply a problem of medical science being beaten by nature; human action and perverse incentives play a major role in its development. The misuse of antibiotics in the medical, veterinary and agricultural sectors, which ...
This update of the Guidelines for poison control, entitled Guidelines for establishing a poison centre, reflects the development of the role of poison centres in public health and the sound management of chemicals, described in section 1, and the opportunities provided by new technology. Assessments...
Produced by UNICEF and IRC, with the support of the German Corporation for International Cooperation GmbH (GIZ) and the generous funding from the German Federal Ministry of Economic Cooperation and Development (BMZ), the Caring for Child Survivors of Sexual Abuse (CCS) Resource Package (Second Editi...
Antibiotic resistant bacteria are spreading at an alarming rate and some bacterial infections may once again be untreatable. Antibiotic resistance (ABR), conservatively calculated, causes more than 500 000 deaths every year. This number is projected to rise dramatically if radical actions are not ta...
The second edition of the WHPCA Global Atlas of Palliative Care was launched during World Hospice & Palliative Care Day 10 October. The Atlas is an update of the original WHPCA/WHO Global Atlas of Palliative care at the end of life published in 2014. It is full of useful facts and figures to support...
During this work, a survey on essential medicines availability was conducted. This article was first written on this subject for sharing the poor financial availability of the essential medicines in the hospital and secondly, a call for an action to be taken in improving hospital pharmacies developm...
The harmful use of alcohol causes approximately 3 million deaths every year and the overall burden of disease and injuries attributable to alcohol consumption remains unacceptably high. The pace of development and implementation of alcohol policies has been uneven in WHO regions, and resources and c...
The most frequent health problems of newly arrived refugees and migrants include accidental injuries, hypothermia, burns, gastrointestinal illnesses, cardiovascular events, pregnancy- and delivery-related complications, diabetes and hypertension. Female refugees and migrants frequently face specific...
Infectious diseases like COVID-19 can disrupt the environments in which children grow and develop. Disruptions to families, friendships, daily routines and the wider community can have negative consequences for children’s well-being, development and protection. In addition, measures used to preven...
New assessment guidelines for measuring the overall impact of mental health problems in Latin America have served as a catalyst for countries to review their mental health policies. Latin American countries have taken various steps to address long-standing problems such as structural difficulties, s...
This document outlines the evaluation process that WHO undertakes to assess novel tools and strategies targeted at VBDs. Its aim is to articulate the linkage between the generation of evidence that demonstrates public health impact of novel interventions, and the development of policy recommendation...
This document provides guidance on the implementation of the shielding approach in urban areas in LICs and crisis-affected regions. It is intended for the community itself, national and local governance institutions, and humanitarian and development actors operating in the country.
This report provides an overview of the Key findings of the Rwanda 2014-2015 Demographic and Health Survey (RDHS). The 2014-15 Rwanda Demographic and Health Survey (RDHS) was designed to provide data for monitoring the population and health situation in Rwanda. The 2014-15 RDHS is the fifth Demogra...
Tuberculosis (TB) control in the African Region has evolved since the disease was declared a global emergency by the World Health Organization (WHO) in 1993. Member States have adopted and implemented successive global and regional strategies and resolutions, with demonstrable positive impacts on in...
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Kyrgyzstan. This report provides evidence through three analyses that NCDs reduce economic outp...
